Cargando…

Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold

BACKGROUND: Development of a pre-vascularized tissue-engineered construct with intrinsic vascular system for cell growth and tissue formation still faces many difficulties due to the complexity of the vascular network of natural bone tissue. The present study was to design and form a new vascularize...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei, Huang, Xin, Shen, Jacson, Wang, Chunsheng, Dang, Xiaoqian, Mankin, Henry, Duan, Zhenfeng, Wang, Kunzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826526/
https://www.ncbi.nlm.nih.gov/pubmed/24209783
http://dx.doi.org/10.1186/1471-2474-14-318
_version_ 1782290921430188032
author Yang, Pei
Huang, Xin
Shen, Jacson
Wang, Chunsheng
Dang, Xiaoqian
Mankin, Henry
Duan, Zhenfeng
Wang, Kunzheng
author_facet Yang, Pei
Huang, Xin
Shen, Jacson
Wang, Chunsheng
Dang, Xiaoqian
Mankin, Henry
Duan, Zhenfeng
Wang, Kunzheng
author_sort Yang, Pei
collection PubMed
description BACKGROUND: Development of a pre-vascularized tissue-engineered construct with intrinsic vascular system for cell growth and tissue formation still faces many difficulties due to the complexity of the vascular network of natural bone tissue. The present study was to design and form a new vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nHA-PA 66 scaffold. METHODS: rADSCs were pre-differentiated to endothelial cells (rADSCs-Endo) and then incorporated in nHA-PA 66 scaffolds in vitro. Subsequently, in vivo experiments were carried out according to the following groups: Group A (rADSCs-Endo/nHA-PA 66 scaffold with arteriovenous vascular bundle), Group B (rADSCs/nHA-PA 66 scaffold with arteriovenous vascular bundle); Group C (nHA-PA66 scaffold with arteriovenous vascular bundle), Group D (nHA-PA 66 scaffold only). The vessel density and vessel diameter were measured based on histological and immunohistochemical evaluation, furthermore, the VEGF-C, FGF-2 and BMP-2 protein expressions were also evaluated by western blot analysis. RESULTS: The results of in vivo experiments showed that the vessel density and vessel diameter in group A were significantly higher than the other three groups. Between Group B and C, no statistical difference was observed at each time point. In accordance with the results, there were dramatically higher expressions of VEGF-C and FGF-2 protein in Group A than that of Group B, C and D at 2 or 4 weeks. Statistical differences were not observed in VEGF-C and FGF-2 expression between Group B and C. BMP-2 was not expressed in any group at each time point. CONCLUSIONS: Compared with muscular wrapping method, arteriovenous vascular bundle implantation could promote vascularization of the scaffold; and the angiogenesis of the scaffold was significantly accelerated when pre-differentiated rADSCs (endothelial differentiation) were added. These positive results implicate the combination of pre-differentiated rADSCs (endothelial differentiation) and arteriovenous vascular bundle may achieve rapidly angiogenesis of biomaterial scaffold.
format Online
Article
Text
id pubmed-3826526
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38265262013-11-14 Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold Yang, Pei Huang, Xin Shen, Jacson Wang, Chunsheng Dang, Xiaoqian Mankin, Henry Duan, Zhenfeng Wang, Kunzheng BMC Musculoskelet Disord Research Article BACKGROUND: Development of a pre-vascularized tissue-engineered construct with intrinsic vascular system for cell growth and tissue formation still faces many difficulties due to the complexity of the vascular network of natural bone tissue. The present study was to design and form a new vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nHA-PA 66 scaffold. METHODS: rADSCs were pre-differentiated to endothelial cells (rADSCs-Endo) and then incorporated in nHA-PA 66 scaffolds in vitro. Subsequently, in vivo experiments were carried out according to the following groups: Group A (rADSCs-Endo/nHA-PA 66 scaffold with arteriovenous vascular bundle), Group B (rADSCs/nHA-PA 66 scaffold with arteriovenous vascular bundle); Group C (nHA-PA66 scaffold with arteriovenous vascular bundle), Group D (nHA-PA 66 scaffold only). The vessel density and vessel diameter were measured based on histological and immunohistochemical evaluation, furthermore, the VEGF-C, FGF-2 and BMP-2 protein expressions were also evaluated by western blot analysis. RESULTS: The results of in vivo experiments showed that the vessel density and vessel diameter in group A were significantly higher than the other three groups. Between Group B and C, no statistical difference was observed at each time point. In accordance with the results, there were dramatically higher expressions of VEGF-C and FGF-2 protein in Group A than that of Group B, C and D at 2 or 4 weeks. Statistical differences were not observed in VEGF-C and FGF-2 expression between Group B and C. BMP-2 was not expressed in any group at each time point. CONCLUSIONS: Compared with muscular wrapping method, arteriovenous vascular bundle implantation could promote vascularization of the scaffold; and the angiogenesis of the scaffold was significantly accelerated when pre-differentiated rADSCs (endothelial differentiation) were added. These positive results implicate the combination of pre-differentiated rADSCs (endothelial differentiation) and arteriovenous vascular bundle may achieve rapidly angiogenesis of biomaterial scaffold. BioMed Central 2013-11-08 /pmc/articles/PMC3826526/ /pubmed/24209783 http://dx.doi.org/10.1186/1471-2474-14-318 Text en Copyright © 2013 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Pei
Huang, Xin
Shen, Jacson
Wang, Chunsheng
Dang, Xiaoqian
Mankin, Henry
Duan, Zhenfeng
Wang, Kunzheng
Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title_full Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title_fullStr Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title_full_unstemmed Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title_short Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
title_sort development of a new pre-vascularized tissue-engineered construct using pre-differentiated radscs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826526/
https://www.ncbi.nlm.nih.gov/pubmed/24209783
http://dx.doi.org/10.1186/1471-2474-14-318
work_keys_str_mv AT yangpei developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT huangxin developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT shenjacson developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT wangchunsheng developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT dangxiaoqian developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT mankinhenry developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT duanzhenfeng developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold
AT wangkunzheng developmentofanewprevascularizedtissueengineeredconstructusingpredifferentiatedradscsarteriovenousvascularbundleandporousnanohydroxyapatidepolyamide66scaffold